NANEXA: First license with Moderna an important validation of PharmaShell

Analys, Research

The announcement of Nanexa’s first licensing deal marks a meaningful validation of the PharmaShell platform, as Moderna, a global leader...

Read More

NANEXA: Intensified focus on deals amid growing funding pressure

Analys, Research

Nanexa’s Q3 report underscores a pivotal moment for the company. While interest in its PharmaShell technology remains strong, with...

Read More

CINDRIGO HOLDINGS: Powering Europe’s clean baseload transition with LSE listing and first revenues

Research

Johan Widmark | 2025-10-30 17:00  Read the report in PDF here Executive Summary  With the admission to the London Stock Exchange Main...

Read More

PROLIGHT: Financing and partner interest strengthen case ahead of regulatory study

Analys, Research

Johan Widmark | 2025-08-29 08:00 READ REPORT IN PDF In Q2, Prolight reported initial positive data from its ongoing whole blood study at St...

Read More

CRUNCHFISH: Improved outlook with NPCI adoption and global validation

Analys, Research

Crunchfish’s new go-to-market strategy for offline payments, splitting the solution into terminals for payment networks and wallets for...

Read More

PROLIGHT: Positive patient data and patent approval strengthen case for Psyros

Analys, Research

Johan Widmark | 2025-06-18 08:00 READ REPORT IN PDF Key milestone for readiness Prolight has reported positive interim results from the...

Read More

CRUNCHFISH: Third time a charm? New offline strategy targets system integration

Analys, Research

With its third attempt to scale offline payments in India, Crunchfish hopes that its new Offline Terminal Infrastructure (OTI) will mark a...

Read More

PROLIGHT: Gearing up for commercialisation with strong insider backing

Analys, Research

Johan Widmark | 2025-05-23 08:00 READ REPORT IN PDF Strong insider commitment signals confidence As expected, Prolight has now announced a...

Read More

NANEXA: Clinical milestones align ahead of phase Ib/II and licensing push

Analys, Research

Nanexa continues to strengthen the foundation for the upcoming Phase Ib/II study in the NEX-22 project, with preliminary PK data from the...

Read More

PROLIGHT: Positive results from the pre-clinical validation study de-risk the full clinical validation

Analys, Research

Following the many recent grants, notices of allowance and intention to grant patents in Europe and the US, and the arrival of the first of...

Read More

For new research on growth stocks, sign up to our newsletter